Vitamin C increases surface cell turnover, which removes dull and dead skin cells
doi: 10.3389/fphar.2026.1844144 Received 31 March 2026 Revised 26 June 2026 Accepted 29 June 2026 Published 27 July 2026 Volume 17 - 2026 Edited by Qingbin Cui, University of Toledo College of Medicine and Life Sciences, United States Reviewed by Kaushik Neogi, Deemed to be University, India Long Wu, Wuhan University, China Updates Copyright 2026 Lofaro, Ferri, Mazzilli, Bonacorsi, Simonini and Boraldi
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Glutathione should be handled only in an appropriate laboratory setting using procedures suitable for peptide-based research chemicals
[DOI] [PubMed] [Google Scholar] Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M (2007) Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction
Contact Reset IV today to find out what glutathione IV therapy can do for you!
